ストックスクリーナーアプリを入手
10.12
1.45%
0.145
アフターアワーズ：
10.05
-0.075
-0.74%
Dbv Technologies Adr (DBVT) 最新ニュース
DBV Technologies SA (DBV.HA) Stock Price, News, Quote & History - Yahoo! Finance Canada
DBV Technologies SA (DBV.HA) Interactive Stock Chart - Yahoo! Finance Canada
DBVT Q2 2026 Earnings: Wider-Than-Expected Loss Keeps the Focus on Pipeline ExecutionBanking Earnings Report - https://www.dars.gov.et/
DBV Technologies Submits FDA Biologics License Application for VIASKIN Peanut Patch in Children Ages 4-7 - Kalkine Media
DBV Technologies annonce le dépôt de sa demande de licence biologique (BLA) auprès de la Food and Drug Administration des Etats-Unis pour le patch VIASKIN® Peanut destiné aux enfants âgés de 4 à 7 ans. - GlobeNewswire Inc.
DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years - GlobeNewswire Inc.
DBVT Stock Price, Quote & News - Syfe
DBV Technologies S.A. (DBV.PA) Stock Price, News, Quote & History - Yahoo! Finance Canada
DBVT Slides As DBV Technologies Leads Biotech ADR Losers - StocksToTrade
DBVT Slides As DBV Technologies Leads European Biotech Declines - timothysykes.com
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock? - Eastern Progress
Zai Lab LimitedADR Peer Comparison – Compare with Others - valueresearchonline.com
DBV Technologies to Participate in Upcoming September Investor Conferences - GlobeNewswire
A food-allergy treatment company will join three New York events in September - Stock Titan
Mesoblast LimitedADR Peer Comparison – Compare with Others - Value Research
DBV Technologies (DBVT) Edges Higher as Allergy Franchise Holds Above Key SupportATR Stop - dars.gov.et
DBV Technologies (DBVT) Edges Higher as Allergy Franchise Holds Above Key SupportMutual Fund Flow - siam.in
DBV Technologies (DBVT) Edges Higher as Allergy Franchise Holds Above Key SupportChannel Breakout - www.dars.gov.et
DBV Technologies (DBVT) Edges Higher as Allergy Franchise Holds Above Key SupportMomentum Stock Picks - www.dars.gov.et
DBV Technologies (DBVT) Edges Higher as Allergy Franchise Holds Above Key SupportBPI Bear Correction - dars.gov.et
DBV (DBVT) Quarterly Scorecard: The Bottom-Line Figure Trails Its Comparison at the Close; Market Reaction: Shares Move 2.14% Higher in the Latest ReadingEarnings Surprise Score - careplusvn.com
DBV (DBVT) Quarterly Scorecard: The Bottom-Line Figure Trails Its Comparison at the Close; Market Reaction: Shares Move 2.14% Higher in the Latest ReadingEarnings Quality Score - dars.gov.et
DBV (DBVT) Quarterly Scorecard: The Bottom-Line Figure Trails Its Comparison at the Close; Market Reaction: Shares Move 2.14% Higher in the Latest ReadingEarnings Beat Alert - dars.gov.et
DBV Technologies (NASDAQ:DBVT) Shares Up 6.2%Here's Why - MarketBeat
European ADRs Started The Week Slightly Higher In US Trading - Finimize
DBVT Q2 2026 Earnings: Wider-than-Expected Loss Reflects Pipeline Investment PressuresPost-Earnings Drift - careplusvn.com
MPM BioImpact LLC discloses 6.2% stake in DBV Technologies (DBVT) - Stock Titan
DBV technologies S.A. (ADR) (DBV1.SG) balance sheet - Yahoo Finance UK
DBV Technologies (NASDAQ:DBVT) Stock Price Up 8.4%Time to Buy? - MarketBeat
RA Capital discloses DBV Technologies (DBVT) 5.8% ownership via ADS holding - Stock Titan
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq - The Manila Times
DBV Technologies Announces Sale of Approximately $50 - GlobeNewswire
Form S-3ASR DBV TECHNOLOGIES S.A. For: 27 July By Investing.com - Investing.com Canada
Form S-3ASR DBV TECHNOLOGIES S.A. For: 27 July By Investing.com - Investing.com Nigeria
Spyre Therapeutics (SYRE) Receives a Buy from Guggenheim - The Globe and Mail
Europe’s US-Listed ADRs Edged Higher Late Friday Morning - Finimize
DBV Technologies: Viaskin's FDA Path Still Leaves Room For More Upside (NASDAQ:DBVT) - Seeking Alpha
DBV Technologies on Track for Lowest Close Since December 2025 -- Data Talk - Moomoo
DBV Technologies stock falls on $150M share offering plan - Investing.com
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales - The Manila Times
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales - markets.businessinsider.com
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales - GlobeNewswire
DBV Technologies S.A. - Via Ritzau
Cantor Fitzgerald reiterates Overweight on DBV Technologies stock - investing.com
DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update - markets.businessinsider.com
DBV Technologies narrows Q2 loss, funds operations into Q3 2027 - scanx.trade
DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Report - markets.businessinsider.com
DBV Technologies (NASDAQ: DBVT) sees $174.9M cash and Q3 2027 runway - Stock Titan
DBV Technologies Announces the Filing of its 2026 Half-Year - GlobeNewswire
DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update - The Manila Times
5.91%
2.85%
大文字化:
|
ボリューム (24 時間):